KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Change in Inventory (2016 - 2026)

Neogenomics filings provide 17 years of Change in Inventory readings, the most recent being $1.3 million for Q1 2026.

  • On a quarterly basis, Change in Inventory fell 57.97% to $1.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$210000.0, a 102.2% decrease, with the full-year FY2025 number at $1.5 million, down 42.83% from a year prior.
  • Change in Inventory hit $1.3 million in Q1 2026 for Neogenomics, up from $28000.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $4.1 million in Q2 2025 to a low of -$5.6 million in Q3 2025.
  • Median Change in Inventory over the past 5 years was $688000.0 (2023), compared with a mean of $415705.9.
  • The widest YoY moves for Change in Inventory: up 1034.16% in 2024, down 2018.0% in 2024.
  • Neogenomics' Change in Inventory stood at $697000.0 in 2022, then plummeted by 71.02% to $202000.0 in 2023, then surged by 1034.16% to $2.3 million in 2024, then crashed by 98.78% to $28000.0 in 2025, then surged by 4439.29% to $1.3 million in 2026.
  • The last three reported values for Change in Inventory were $1.3 million (Q1 2026), $28000.0 (Q4 2025), and -$5.6 million (Q3 2025) per Business Quant data.